Thomas Cusack
Net worth: 2 059 $ as of 2026-05-30
Net worth: 2 059 $ as of 2026-05-30
Thomas Patrick Cusack is currently Managing Director at Starboard Value LP since 2017, a position started in 2011.
Mr. Cusack is also Director at Heron Therapeutics, Inc. starting in 2025.
Formerly, Mr. Cusack was an Analyst at Lehman Brothers Holdings, Inc. in 2008 and an Associate at Barclays Capital, Inc. in 2011.
Mr. Cusack completed undergraduate education at The Leonard N Stern School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-13 | 2,367 ( 0% ) | 2 059 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| HERON THERAPEUTICS, INC. | Director/Board Member | 2025-10-26 |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value invests primarily, although not exclusively, in the securities of US public companies they believe are deeply undervalued by the marketplace and likely to experience a significant appreciation in value as a result of operational improvements or a change in ownership, corporate direction or management or improved corporate governance. The firm typically conducts a thorough analysis of management, capital structure and corporate governance related issues, valuing the company using a traditional, fundamental, and value-based approach. Starboard Value is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Analyst-Equity | 2010-12-31 |
| Companies | Position | End |
|---|---|---|
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Corporate Officer/Principal | 2008-09-29 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2011-05-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Lehman Brothers Holdings, Inc.
Lehman Brothers Holdings, Inc. Financial ConglomeratesFinance Provides financial and investment banking services | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Starboard Value LP
Starboard Value LP Investment ManagersFinance Starboard Value invests primarily, although not exclusively, in the securities of US public companies they believe are deeply undervalued by the marketplace and likely to experience a significant appreciation in value as a result of operational improvements or a change in ownership, corporate direction or management or improved corporate governance. The firm typically conducts a thorough analysis of management, capital structure and corporate governance related issues, valuing the company using a traditional, fundamental, and value-based approach. Starboard Value is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions